Available Until 7/30/2023

ASHP/SCCM COVID-19 Pharmacology Debates: Steroid and Antiviral Use in COVID-19 Patients

ACPE Activity Number: None
Release Date: July 30, 2020
Expirations Date: July 30, 2023
Activity Type: Knowledge-based  
CE Credits: None
Activity Fee: Members/Non-Member – Free


Join ASHP and the SCCM in their second series of therapeutic debates in the management of COVID-19.  In our first debate, this month’s content matter experts will review the latest literature and debate the use of steroids for the treatment of COVID-19. In our second debate, our infectious diseases pharmacists will debate the use of antivirals in the treatment course of COVID-19.


Gretchen Sacha, Pharm.D., BCCCP
Critical Care Pharmacy Specialist
Cleveland Clinic 

Krutika N. Mediwala, Pharm.D., BCPS, BCIDP
Clinical Pharmacy Specialist
Infectious Diseases/Antimicrobial Stewardship Residency Program Director
Affiliate Assistant Professor
Medical University of South Carolina
College of Pharmacy 

Mitchell Buckley, Pharm.D., FASHP, FCCM, FCCP, BCCCP, BCPS
Clinical Pharmacy Specialist
Banner University Medical Center
Phoenix, Arizona, USA 

Amy L. Dzierba, Pharm.D., FCCM, FCCP, BCCCP
Clinical Pharmacy Manager, Adult Critical Care
PGY2 Pharmacy Residency Program Director Critical Care
New York-Presbyterian Hospital
Columbia University Irving Medical Center
New York, New York, USA


Mojdeh Heavner, PharmD, BCPS, BCCCP, FCCM
Associate Professor and Vice Chair of Clinical Services
Department of Pharmacy Practice and Science
University of Maryland School of Pharmacy